FIELD: medicine.
SUBSTANCE: pharmaceutical composition in form of lyophilisate with complexiant for preparation of solution for parenteral application to treat tuberculosis represents complex in form of prothionamide lyophilisate, which includes in composition water-soluble derivatives of β-cyclodextrine, and in case of addition of pharmaceutically acceptable diluent applicable for intravenous introduction. Pharmaceutical composition is obtained by dissolution of prothionamide substance in pharmaceutically acceptable acid (such as chloromethane, sulphuric, ascorbic, citric, etc.) in equimolar ratio or with up to 20% excess, obtaining complex with cyclodextrine derivative in equimolar ratio or with excess of cyclodextrine derivative up to 20%, sterile filtering of solution, pouring into reservoirs and lyophilic drying. As diluent applied is solution of sodium chloride, glucose and other pharmaceutically acceptable solutions. Finished medication is provided with pH corrector (sodium hydrocarbonate solution).
EFFECT: medication is stable in storage and is applied for preparation of solution for intravenous drip-feed.
11 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION IN FORM OF LYOPHILISATE FOR PREPARATION OF SOLUTION FOR PARENTERAL APPLICATION AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2545903C1 |
ANTITUBERCULOUS COMPOSITION AND METHOD FOR PREPARING IT | 2011 |
|
RU2472512C1 |
MACOZINONE-BASED PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TUBERCULOSIS INCLUDING MULTI- AND EXTENSIVELY DRUG-RESISTANT FORMS THEREOF | 2020 |
|
RU2751163C1 |
PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY IN INJECTION FORM (VERSIONS) | 2013 |
|
RU2563211C2 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
TUBERCULOUS AGENT AS SOLUTION FOR INJECTION | 2007 |
|
RU2358742C2 |
SYNERGIC ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSERINE AND ZINC CONTAINING CONNECTION | 2016 |
|
RU2620857C1 |
LYOPHILISATE BASED ON PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS FOR PREPARING A RADIOPHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTIONS FOR TREATING PROSTATE CANCER, RADIOPHARMACEUTICAL COMPOSITION BASED ON IT FOR TREATING PROSTATE CANCER AND METHOD FOR PREPARING RADIOPHARMACEUTICAL COMPOSITION | 2023 |
|
RU2817970C1 |
STABLE PHARMACEUTICAL COMPOSITION OF 5,10-METHYLENTETRAHYDROFOLATE | 2004 |
|
RU2343923C2 |
PHARMACEUTICAL COMPOSITION SHOWING PROLONGED ANTITUBERCULOSIS EFFECT | 1999 |
|
RU2169565C1 |
Authors
Dates
2015-04-10—Published
2013-11-19—Filed